These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 31053466

  • 1. Physician-pharmacist collaboration on chronic non-cancer pain management during the opioid crisis: A qualitative interview study.
    Kang I, Urick B, Vohra R, Ives TJ.
    Res Social Adm Pharm; 2019 Aug; 15(8):1027-1031. PubMed ID: 31053466
    [Abstract] [Full Text] [Related]

  • 2. Physicians' perspectives of pharmacist-physician collaboration in the United Arab Emirates: Findings from an exploratory study.
    Hasan S, Stewart K, Chapman CB, Kong DCM.
    J Interprof Care; 2018 Sep; 32(5):566-574. PubMed ID: 29589781
    [Abstract] [Full Text] [Related]

  • 3. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods.
    Snyder ME, Zillich AJ, Primack BA, Rice KR, Somma McGivney MA, Pringle JL, Smith RB.
    Res Social Adm Pharm; 2010 Dec; 6(4):307-23. PubMed ID: 21111388
    [Abstract] [Full Text] [Related]

  • 4. Pharmacist, physician, and patient opinions of pharmacist-treated minor ailments and conditions.
    McKeirnan KC, Garrelts MacLean L.
    J Am Pharm Assoc (2003); 2018 Dec; 58(6):599-607. PubMed ID: 30266565
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Family physicians' perceptions of pharmacists prescribing in Alberta.
    Faruquee CF, Khera AS, Guirguis LM.
    J Interprof Care; 2020 Dec; 34(1):87-96. PubMed ID: 31043099
    [Abstract] [Full Text] [Related]

  • 7. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C, Unni E, Montuoro J, Ogborn DB.
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [Abstract] [Full Text] [Related]

  • 8. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM, MacKeigan L, Thompson A, Kuluski K, McCarthy LM.
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [Abstract] [Full Text] [Related]

  • 9. Communication Experiences of DATA-Waivered Physicians with Community Pharmacists: A Qualitative Study.
    Ventricelli DJ, Mathis SM, Foster KN, Pack RP, Tudiver F, Hagemeier NE.
    Subst Use Misuse; 2020 May; 55(3):349-357. PubMed ID: 31591924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Physician-reported factors that encourage collaboration with community pharmacists.
    Pezzino NC, Marciniak MW, Smith MG, Ferreri SP.
    J Am Pharm Assoc (2003); 2017 May; 57(3S):S279-S283.e2. PubMed ID: 28411013
    [Abstract] [Full Text] [Related]

  • 12. A narrative review of risk mitigation strategies in the management of opioids for chronic pain and palliative care in older adults: interprofessional collaboration with the pharmacist.
    Mohammad I, Garwood CL, Binns-Emerick L.
    Ann Palliat Med; 2024 Jul; 13(4):901-913. PubMed ID: 38735692
    [Abstract] [Full Text] [Related]

  • 13. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
    Wibowo Y, Sunderland B, Hughes J.
    Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. How physician and community pharmacist perceptions of the community pharmacist role in Australian primary care influence the quality of collaborative chronic disease management.
    Rieck A, Pettigrew S.
    Qual Prim Care; 2013 May; 21(2):105-11. PubMed ID: 23735691
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Challenges faced with opioid prescriptions in the community setting - Australian pharmacists' perspectives.
    Makdessi CJ, Day C, Chaar BB.
    Res Social Adm Pharm; 2019 Aug; 15(8):966-973. PubMed ID: 30819418
    [Abstract] [Full Text] [Related]

  • 18. Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients.
    Lalonde L, Hudon E, Goudreau J, Bélanger D, Villeneuve J, Perreault S, Blais L, Lamarre D.
    Res Social Adm Pharm; 2011 Sep; 7(3):233-45. PubMed ID: 21272548
    [Abstract] [Full Text] [Related]

  • 19. Interprofessional prescription opioid abuse communication among prescribers and pharmacists: A qualitative analysis.
    Hagemeier NE, Tudiver F, Brewster S, Hagy EJ, Ratliff B, Hagaman A, Pack RP.
    Subst Abus; 2018 Jan 02; 39(1):89-94. PubMed ID: 28799863
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.